HPS Pharmacies wish to advise that Merck Sharp & Dohme Australia, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:
Renitec Plus® tablets
Enalapril / hydrochlorothiazide 20/6mg
The only affected batch is: L005163 with an expiry date of 29th October 2016.
This recall has been initiated due to the discovery of blisters containing Renitec® 20mg tablets inside a small number of Renitec Plus® cartons.
Please inspect your stocks and quarantine all products from the batches listed above for return to your supplier for a refund.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Merck Sharp & Dohme on 1800 678 883.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.